Project Grant HT94252410325
Award Date
5/15/24
Completion Date
5/14/27
Dollars Obligated
$780K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The federal Project Grant award of $2,271,024.00 was provided by the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, to the University of Colorado-Denver. The award, effective November 1, 2024, supports a four-year research project to improve understanding of next-generation immunotherapy responses in metastatic uveal melanoma. The University of Colorado-Denver, a major public research university with a strong focus on medical...
The U.S. Department of the Army Medical Command awarded a $1,260,839 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, awarded on May 1, 2025, supports research to "Target EHMT1/2 to Overcome Therapy-Resistant Ovarian Cancer" with a performance period through April 30, 2029. The University of Colorado-Denver, a major public research...
This federal Project Grant award in the amount of $624,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Colorado-Denver. The grant will fund a 2-year project from July 1, 2024 to June 30, 2026 to investigate the use of cell-free DNA to define MYC activity in osteosarcoma. The University of Colorado-Denver, a major public research institution, will serve as the primary awardee and perform the research...
This Project Grant award of $577,680 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Colorado to target the EHMT1/2 enzyme as a potential treatment for therapy-resistant ovarian cancer. The research aims to overcome limitations of current ovarian cancer therapies, with the ultimate goal of improving outcomes for military personnel and the general public affected by this disease. The award period...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,200,000 Project Grant to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The award, with an effective date of Sep 30, 2023 and ultimate completion date of Sep 29, 2026, will fund research focused on "Prevention and Treatment of Frostbite Infection with Antimicrobial Pharmacokinetic Analysis" to be conducted at the University's...
The University of Colorado-Denver has been awarded a $1,130,984 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "DEFINING AND TARGETING CHROMOBOX2 (CBX2)-MEDIATED CHEMORESISTANCE IN HIGH GRADE SEROUS CARCINOMA". The grant will support the university's research efforts to investigate novel approaches for overcoming chemoresistance in high-grade serous carcinoma, a form of ovarian cancer, over a...
The University of Colorado Denver was awarded a $3,067,768 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to investigate the mechanisms underlying brain metastatic progression in ER+ breast cancer. The three-year award running from September 1, 2022 to August 31, 2025 will support research into medical solutions for the battlefield by transforming healthcare through innovative and impactful...
This federal Project Grant award of $1,008,313.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support melanoma research conducted by The Regents of the University of California, San Francisco (UCSF). The funding will enable UCSF's team of researchers to pursue advanced, innovative scientific investigations focused on transforming healthcare for military service members and the broader public. The 3-year research effort, spanning...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
The Defense Health Agency awarded a $320,000 Project Grant to the Regents of the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2025 to determine the mechanisms underlying remyelination by surviving oligodendrocytes. The research aims to advance understanding of how the central nervous system repairs myelin sheaths, with potential implications for treating multiple...